The concept of health-adjusted income recognizes that conventional measures of national income, such as gross domestic product (GDP), do not include the intrinsic value of health and longevity. Building on the work of the Lancet Commission on Investing in Health, including its latest report, this presentation discusses ongoing efforts to develop a more comprehensive measure.
Dean Jamison is Emeritus Professor in the UCSF Institute for Global Health Sciences and is on the leadership team for the Guidelines for Benefit-Cost Analysis project, led by CHDS faculty Lisa A. Robinson and James K. Hammitt.
Related news: Reducing Air Pollution in Mexico City
Related news: Goldie and Summers Guests at Benefit-Cost Analysis Workshop